I agree that this site is using cookies. You can find further informations here.
X
Sallinen, Hanna
107  results:
Search for persons X
?
1

Neoadjuvant chemotherapy induces an elevation of tumour app..:

Reijonen, Milja ; Holopainen, Erikka ; Arponen, Otso...
BMC Cancer.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
2

Dynamic contrast-enhanced MRI to characterize angiogenesis ..:

Lindgren, Auni ; Anttila, Maarit ; Arponen, Otso...
European Journal of Radiology.  165 (2023)  - p. 110925 , 2023
Link: https://doi.org/10.1016/..
 
?
3

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined wit..:

Kujala, Anni ; Valkonen, Elina ; Sallinen, Hanna...
Frontiers in Medicine.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
4

Treatment Free Intervals after Subsequent Chemotherapy Line..:

Sallinen, Hanna ; Rintanen, Vivi ; Keski-Nisula, Leea.
Journal of Cancer Therapy.  12 (2021)  6 - p. 346-357 , 2021
Link: https://doi.org/10.4236/..
 
?
5

Robotic-assisted laparoscopy is a feasible method for resec..:

Hiltunen, Janika ; Eloranta, Marja-Liisa ; Lindgren, Auni...
Journal of International Medical Research.  49 (2021)  8 - p. 030006052110327 , 2021
Link: https://doi.org/10.1177/..
 
?
6

Evaluation of Ovarian Cancer Care at the End of Life in a S..:

Sallinen, Hanna ; Rintanen, Vivi ; Keski-Nisula, Leea.
Journal of Cancer Therapy.  12 (2021)  2 - p. 86-96 , 2021
Link: https://doi.org/10.4236/..
 
?
7

High expression of Tie-2 predicts poor prognosis in primary..:

Sopo, Minna ; Sallinen, Hanna ; Hämäläinen, Kirsi...
PLOS ONE.  15 (2020)  11 - p. e0241484 , 2020
Link: https://doi.org/10.1371/..
 
?
8

Dynamic contrast-enhanced perfusion parameters in ovarian c..:

Lindgren, Auni ; Anttila, Maarit ; Rautiainen, Suvi...
PLOS ONE.  14 (2019)  8 - p. e0221340 , 2019
Link: https://doi.org/10.1371/..
 
?
9

Prognostic value of preoperative dynamic contrast-enhanced ..:

Lindgren, Auni ; Anttila, Maarit ; Arponen, Otso...
European Journal of Radiology.  115 (2019)  - p. 66-73 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher..:

Sopo, Minna ; Anttila, Maarit ; Hämäläinen, Kirsi...
BMC Cancer.  19 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
11

Primary and metastatic ovarian cancer: Characterization by ..:

Lindgren, Auni ; Anttila, Maarit ; Rautiainen, Suvi...
European Radiology.  27 (2017)  9 - p. 4002-4012 , 2017
Link: https://doi.org/10.1007/..
 
?
12

Serum angiopoietin-2 and soluble VEGFR-2 levels predict mal..:

Sallinen, Hanna ; Heikura, Tommi ; Koponen, Jonna...
BMC Cancer.  14 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
13

Antiangiogenic gene therapy with soluble VEGF‐receptors ‐1,..:

Sopo, Minna ; Anttila, Maarit ; Sallinen, Hanna...
International Journal of Cancer.  131 (2012)  10 - p. 2394-2401 , 2012
Link: https://doi.org/10.1002/..
 
?
14

In vivo SPECT/CT imaging of human orthotopic ovarian carcin..:

Huhtala, Tuulia ; Laakkonen, Pirjo ; Sallinen, Hanna..
Nuclear Medicine and Biology.  37 (2010)  8 - p. 957-964 , 2010
Link: https://doi.org/10.1016/..
 
?
15

Antiangiogenic Gene Therapy With Soluble VEGFR-1, -2, and -..:

Sallinen, Hanna ; Anttila, Maarit ; Narvainen, Johanna...
Molecular Therapy.  17 (2009)  2 - p. 278-284 , 2009
Link: https://doi.org/10.1038/..
 
1-15